High-resolution solution structure of human pNR-2/pS2: A single trefoil motif protein

Journal of Molecular Biology

Volumn 267, Issue 2, 1997, Pages 418-432

  Polshakov, Vladimir I ^a   Williams, Mark A ^b   Gargaro, Angelo R ^b   Frenkiel, Thomas A ^b   Westley, Bruce R ^c   Chadwick, Mark P ^c   May, Felicity E B ^c   Feeney, James ^b  

^a Chem Pharmaceutical Res Institute   (Russian Federation)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Nuclear magnetic resonance; pNR 2; Protein structure; pS2; Trefoil motif

Indexed keywords

CYSTEINE; MUTANT PROTEIN; TREFOIL PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISULFIDE BOND; HUMAN; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; RECEPTOR BINDING; STEREOCHEMISTRY; STOMACH EPITHELIUM;

LOTUS; SUIDAE;

EID: 0031588967     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.0896     Document Type: Article

References (74)

1. 15N with side chain Hβ resonances in larger proteins. J. Magn. Reson. 95:1991;636-641.
2. Bartels C., Xia T.-H., Billeter M., Güntert P., Wüthrich K. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR. 5:1995;1-10.
3. Bax A., Pochapsky S. S. Optimised recording of heteronuclear multidimensional NMR spectra using pulse field gradients. J. Magn. Reson. 99:1992;638-643.
4. 15N NMR by enhanced heteronuclear spectoscopy. Chem. Phys. Letters. 69:1980;185-189.
5. Brünger A. T. X-PLOR 3.1. A System for X-ray Crystallography and NMR. 1992;Yale University Press, New Haven, CT.
6. Carr M. D., Bauer C. J., Gradwell M. J., Feeney J. Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. Proc. Natl Acad. Sci. USA. 91:1994;2206-2210.
7. 58. Biochem. J. 308:1995;1001-1007.
8. Chinery R., Cox H. M. Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor. Br. J. Pharmacol. 115:1995;77-80.
9. Chinery R., Playford R. J. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethecin-induced gastric damage in the rat. Clin. Sci. 88:1995;401-403.
10. Chinery R., Bates P. A., De A., Freemont P. S. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Letters. 357:1995;50-54.
11. 1H NMR spectroscopy. Biochemistry. 29:1990;7387-7401.
12. 1H groups with pulse-field gradients and preservation of coherence pathways. J. Magn. Reson. ser. A. 111:1994;121-126.
13. De A., Brown D. G., Gorman M. A., Carr M. D., Sanderson M. R., Freemont P. S. Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. Proc. Natl Acad. Sci. USA. 91:1994;1084-1088.
14. Dignass A., Lynch-Devaney K., Kindon H., Thim L., Podolsky D. K. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J. Clin. Invest. 94:1994;376-383.
15. Engh R. A., Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallog. sect. A. 47:1991;392-400.
16. Gajhede M., Petersen T. N., Henriksen A., Petersen J. F. W., Dauter Z., Wilson K. S., Thim L. Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure. 1:1993;253-262.
17. Gargaro A. R., Frenkiel T. A., Nieto P. M., Birdsall B., Polshakov V. I., Morgan W. D., Feeney J. NMR detection of arginine-ligand interactions in complexes of Lactobacillus casei dihydrofolate reductase. Eur. J. Biochem. 238:1996;435-439.
18. 2O in protein NMR. Application to sensitivity enhancement NOE measurements. J. Am. Chem. Soc. 115:1993;12593-12594.
19. Hahnel E., Joyce R., Sterrett G., Harvey J., Hahnel R. Detection of estradiol-induced messenger RNA (pS2) in uninvolved breast tissue from mastectomies for breast cancer. Breast Cancer Res. Treat. 20:1992;167-176.
20. Hanby A. M., Poulsom R., Singh S., Elia G., Jeffery R. E., Wright N. A. Human spasmolytic polypeptide (hSP) is a major antral peptide. The distribution of the trefoil peptides hSP and pS2 in the stomach. Gastroenterology. 105:1993;1110-1116.
21. Hauser F., Poulsom R., Chinery R., Rogers L. A., Hanby A. M., Wright N. A., Hoffmann W. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc. Natl Acad. Sci. USA. 90:1993;6961-6965.
22. Henry J. A., Nicholson S., Hennessy C., Lennard T. W. J., May F. E. B., Westley B. R. Expression of the estrogen-regulated pNR-2 mRNA in human breast cancer: relation to estrogen receptor mRNA levels and response to tamoxifen therapy. Br. J. Cancer. 61:1989;32-38.
23. Henry J. A., Piggott N. H., Mallick U. K., NIcholson S., Farndon J. R., Westley B. R., May F. E. B. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br. J. Cancer. 63:1991a;615-622.
24. Henry J. A., Bennett M. K., Piggott N. H., Levett D. L., May F. E. B., Westley B. R. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br. J. Cancer. 64:1991b;677-682.
25. Hommel V., Harvey T. S., Driscoll P. C., Campbell I. D. Human epidermal growth factor: high resolution solution structure and comparison with human transforming growth factor a. J. Mol. Biol. 227:1992;271-282.
26. Hoosein N. M., Thim L., Jørgensen K. H., Brattain M. G. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Letters. 247:1989;303-306.
27. Hutchinson E. G., Thornton J. M. PROMOTIF: a program to identify and analyze structural motifs in proteins. Protein Sci. 5:1996;212-220.
28. IUPAC-IUB Commission on Biochemical Nomenclature. Abbreviations and symbols for the description of the conformation of polypeptide chains. J. Mol. Biol. 52:1970;1-17.
29. Jakowlew S. B., Breathnach R., Jeltsch J. M., Masiakowski P., Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucl. Acids Res. 12:1984;2861-2878.
30. Jørgensen K. H., Thim L., Jacobsen H. E. Pancreatic spasmolytic polypeptide (PSP): I. preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul. Pept. 3:1982a;207-219.
31. Jørgensen K. D., Diamant B., Jørgensen K. H., Thim L. Pancreatic spasmolytic polypeptide (PSP). III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul. Pept. 3:1982b;231-243.
32. 15N inverse detected heteronuclear NMR spectroscopy. Application to staphylococcal nuclease. Biochemistry. 28:1989;8972-8979.
33. Koradi R., Billeter M., Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:1996;51-55.
34. Kraulis P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
35. αJ couplings in calcium-free calmodulin using new 2D and 3D water-flip-back methods. J. Biomol. NMR. 4:1994;871-878.
36. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
37. Lasowski R. A., Rullman J. A., MacArthur M. W., Kaptein R., Thornton J. M. AQUA and PROCHECK-NMR: programs for checking the qaulity of protein structures solved by NMR. J. Biomol. NMR. 8:1997;477-486.
38. Lefebvre O., Chenard M.-P., Masson R., Linares J., Dierich A., LeMeur M., Wendling C., Tomasetto C., Chambon P., Rio M.-C. Gastric mucosa abnormalities and tumorigenesis in mic lacking the pS2 trefoil protein. Science. 274:1996;259-262.
39. 15N Overhauser effects. J. Magn. Reson. ser. B. 105:1994;45-51.
40. 15N NMR via proton detected multiquantum coherences: studies of large peptides. J. Am. Chem. Soc. 106:1984;1939-1941.
41. 15N-labelled proteins. J. Am. Chem. Soc. 111:1989;1515-1517.
42. Mashimo H., Wu D.-C., Podolsky D. K., Fishman M. C. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:1996;262-265.
43. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucl. Acids Res. 24:1982;7895-7903.
44. May F. E. B., Westley B. R. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res. 46:1986;6034-6040.
45. May F. E. B., Westley B. R. Identification and characterization of estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 263:1988;12901-12908.
46. McDonald I. K., Thornton J. M. Satisfying hydrogen bonding potential in proteins. J. Biol. Chem. 238:1994;777-793.
47. Mori S., Abeygunawardana C., O'Neil Johnson M., van Zijl P. C. M. Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J. Magn. Reson. ser. B. 108:1995;94-98.
48. Nicholls A., Sharp K. A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:1991;281-296.
49. Nilges M. Calculation of protein structures with ambiguous distance constraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J. Mol. Biol. 245:1995;645-660.
50. Nilges M., Gronenborn A. M., Brünger A. T., Clore G. M. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance constraints: application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. Protein Eng. 2:1988;27-38.
51. Piggott N. H., Henry J. A., May F. E. B., Westley B. R. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J. Pathol. 163:1991;95-104.
52. Playford R. J., Marchbank T., Chinery R., Evison R., Pignatelli M., Boulton R. A., Thim L., Hanby A. M. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology. 108:1995;108-116.
53. Playford R. J., Marchbank T., Goodlad R. A., Chinery R. A., Poulsom R., Hanby A. M., Wright N. A. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl Acad. Sci. USA. 93:1996;2137-2142.
54. Podolsky D. K., Lynch-Devaney K., Stow J. L., Oates P., Murgue B., DeBeaumont M., Sands B. E., Mahida Y. R. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J. Biol. Chem. 268:1993;6694-6702.
55. Polshakov V. I., Frenkiel T. A., Birdsall B., Soteriou A., Feeney J. Determination of stereospecific assignments, torsion-angle constraints, and rotamer populations in proteins using the program AngleSearch. J. Magn. Reson. ser. B. 108:1995a;31-43.
56. Polshakov V. I., Frenkiel T. A., Westley B., Chadwick M., May F., Carr M. D., Feeney J. NMR-based structural studies of the pNR-2/pS2 single domain trefoil peptide. Similarities to porcine spasmolytic peptide and evidence for a monomeric structure. Eur. J. Biochem. 233:1995b;847-855.
57. Prud'homme J. F., Fridlansky F., Le Cunff M., Atger M., Mercier-Bodard C., Pichon M. F., Milgrom E. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA. 4:1985;11-21.
58. Rio M., Bellocq J. P., Daniel J. Y., Tomasetto C., Lathe R., Chenard M. P., Batzenschlager A., Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science. 241:1988;705-708.
59. Ryckaert J.-P., Ciccutti G., Berendsen H. J. C. Numerical-integration of cartesian equations of motion of a system with constraints: molecular dynamics of N-alkanes. J. Comput. Phys. 23:1977;327-351.
60. Rye P. D., Keyte J., Sutcliffe M. J., Bailey K., Walker R. A. Solid phase synthesis of pS2 peptide: suggestion of an alternative trefoil structure. Protein Pept. Letters. 1:1994;54-59.
61. Sands B. E., Podolsky D. K. The trefoil peptide family. Annu. Rev. Physiol. 58:1996;253-273.
62. Schwartz L. H., Koerner F. C., Edgerton S. M., Sawicka J. M., Rio M., Bellocq J. P., Chambon P., Thor A. D. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res. 51:1991;624-628.
63. 15N HSQC experiments optimised to retain full sensitivity. J. Magn. Reson. ser. A. 102:1993;241-245.
64. 15N NMR relaxation measurements. Biochemistry. 31:1992;4394-4406.
65. 1H HSQC spectra of proteins. J. Magn. Reson. ser. A. 107:1994;178-184.
66. Thim A. A new family of growth factor-like peptides. "Trefoil" disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Letters. 250:1989;85-90.
67. Tomasetto C., Rio M.-C., Gautier C., Wolf C., Hareuveni M., Chambon P., Lathe R. hSP, the domain-duplicated homolog of pS2 protein is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J. 9:1990;407-414.
68. Van Zijl P. C. M., Moonen C. T. W. Complete water suppression for solutions of large molecules based on diffusional differences between solute and solvent (DRYCLEAN). J. Magn. Reson. 87:1990;18-25.
69. 15N-enriched proteins. J. Am. Chem. Soc. 115:1993;7772-7777.
70. Wider G., Wüthrich K. A simple experimental scheme using pulse field gradients for coherence-pathway rejection and solvent suppression in phase-sensitive heternocular correlation spectra. J. Magn. Reson. ser. B. 102:1993;239-241.
71. Williams R., Stamp G. H. W., Gilbert C., Pignatelli M., Lalani E.-N. pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel. J. Cell Sci. 109:1996;63-71.
72. 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR. 6:1995;135-140.
73. Wright N. A., Poulsom R., Stamp G. W., Hall P. A., Jeffery R. E., Longcroft J. M., Rio M., Tomasetto C., Chambon P. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol. 162:1990;279-284.
74. Wright N. A., Poulsom R., Stamp G. W., van Noorden S., Sarraf C., Elia G., Ahenen D., Jeffery R., Longcroft J., Pile C., Rio M., Chambon P. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 104:1993;12-20.